OKLO

Oklo Inc. Q1 2025 10-Q Summary

Business Context and Reporting Period

This report covers the quarterly period ended March 31, 2025. Oklo Inc. is an emerging growth company developing advanced fission power plants (Aurora product line) and nuclear fuel recycling technology. The company operates in a single reportable segment focused on research and development, regulatory approvals, and site preparation for commercial deployment. A significant corporate development during the period was the acquisition of Atomic Alchemy, Inc. on February 28, 2025, to expand capabilities in radioisotope production.

Key Financial Metrics

Material Changes vs. Prior Period

• Operating Expenses: Increased by 142.5% to $17.87 million. Research and Development (R&D) expenses rose 114.4% to $7.85 million, and General and Administrative (G&A) expenses rose 170.3% to $10.03 million. Increases were driven by higher headcount, salary growth, stock-based compensation, and professional services.
• Net Loss: Improved significantly to $9.81 million from $24.02 million. This improvement was primarily due to the absence of a $16.79 million loss from the change in fair value of Simple Agreements for Future Equity (SAFEs) recorded in Q1 2024, which converted upon the company's recapitalization in May 2024.
• Other Income: Interest and dividend income surged to $3.65 million from $0.14 million, reflecting higher cash and marketable securities balances.
• Acquisition: The company acquired Atomic Alchemy for a total consideration of $28.42 million ($1.0 million cash and $27.4 million in stock). This resulted in the recognition of $27.5 million in indefinite-lived intangible assets (IPR&D) and $6.72 million in goodwill.
• Liquidity: Total cash and marketable securities increased to $260.7 million, providing a runway for operations for at least one year.

Guidance, Outlook, and Risks

• Outlook: Management expects total net cash used in operating activities for 2025 to range between $65.0 million and $80.0 million. The first commercial Aurora powerhouse deployment is targeted for late 2027 or early 2028.
• Order Book: The company reports a total order book of approximately 14,100 MWe in capacity, driven by non-binding letters of intent and a 12 GW Master Power Agreement with Switch data centers.
• Regulatory Milestones: Oklo has secured a site use permit from the DOE for the Idaho National Laboratory (INL) site and is progressing with the Nuclear Regulatory Commission (NRC) on a custom combined license application.
• Risks:
  • Regulatory Uncertainty: No commercial project is currently operating; success depends on obtaining NRC design, construction, and operating licenses.
  • Internal Controls: Management concluded that disclosure controls and procedures were not effective as of March 31, 2025, due to a material weakness related to infrequent and complex transactions. Remediation is expected by December 31, 2025.
  • Supply Chain: Risks related to accessing high-assay low-enriched uranium (HALEU), recycled fuels, and global supply chain disruptions due to tariffs or geopolitical conflicts.

Investor Verification Checklist

• Verify the status of the material weakness in internal controls and the timeline for remediation.
• Confirm the binding nature of the 14,100 MWe order book, noting that much of it consists of non-binding letters of intent.
• Monitor progress on the NRC custom combined license application and the timeline for the first commercial deployment (late 2027/early 2028).
• Review the integration and revenue potential of the Atomic Alchemy acquisition, specifically the "Abundantia" and "Meitner" projects.
• Assess the sufficiency of the $260.7 million liquidity against the projected $65M-$80M annual cash burn rate.